HomeOGN • NYSE
add
Organon & Co
Previous close
$19.61
Day range
$19.59 - $20.79
Year range
$10.84 - $24.08
Market cap
5.32B USD
Avg Volume
2.19M
P/E ratio
5.18
Dividend yield
5.42%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.62B | 5.46% |
Operating expense | 501.00M | -11.17% |
Net income | 201.00M | 13.56% |
Net profit margin | 12.39 | 7.65% |
Earnings per share | 1.22 | 12.96% |
EBITDA | 518.00M | 14.86% |
Effective tax rate | 14.83% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 693.00M | 50.98% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | -70.00M | — |
Shares outstanding | 255.64M | — |
Price to book | -72.63 | — |
Return on assets | — | — |
Return on capital | 12.95% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 201.00M | 13.56% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Organon & Co. is an example of increasing women's representation on Wall Street with over 50% of its board of directors and executive leadership being female. Wikipedia
Founded
2020
Headquarters
Website
Employees
10,000